Contact PI/Project LeaderGONZALEZ-SCARANO, FRANCISCO A
Awardee OrganizationUNIVERSITY OF PENNSYLVANIA
Description
Abstract Text
HIV encephalopathy (HIVE) is recognized as a major complication of HIV
infection, yet there are many unknown regarding the role of direct viral
infection in its pathogenesis, including which cells harbor virus and
whether some virus strains are more likely to invade the nervous system.
The central hypothesis of this proposal is that virus tropism for cells
of the central nervous system is a critical determinant in the
development of HIVE, and that understanding this relationship will lead
to the development of a rational approach for its treatment.
We will approach this problem with an in vitro system consisting of
cultured microglia, oligodendrocyte and astrocytes obtained from adults
brain, in conjunction with a cell line. NTera 2, that can be
differentiated into post-mitotic neurons. Three specific aims are
proposed: in the first aim we will address the hypothesis that HIV
microglial-tropism and macrophage-tropism may be separable, and survey
both existing and newly isolated viruses to compare replication in
microglia and macrophage. We will also adapt HIV strains of growth in
microglia and, using linker-substitution mutants, analyze the role of the
HIV-1 LTR in microglial replication. The findings from this portion of
the proposal may help explain the finding that HIVE develops in only a
subset of infected individuals, in spite of the fact that most harbor
macrophage-tropic strains. In the second aim we will address the
questions of whether oligodendrocyte are injectable by HIV strain served
from the central nervous system or peripherally, and explore the
possibility that infected microglia could injure oligodendrocyte. This
aim will address the mechanisms underlying myelin pallor, the most
frequent pathological correlate of HIVE. In the third aim, we will
explore the infectability of undifferentiated and differentiated NTera
2 cells by either cell-free or cell-associated mechanisms, and will
examine the neurotoxicity of infected microglia using the specialized
functions characteristic of these post mitotic neurons. This aim will
address the critical role of neurons in the development of dementia using
human cells exclusively.
The results obtained will help us understand the pathogenesis and
pathophysiology of HIVE, and the role of HIV in its development. They
will be important in the future design of treatment protocols.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AIDS dementia complexHIV envelope protein gp120HIV infectionsapoptosisastrocytesbrain cellflow cytometrygenetic strainhuman immunodeficiency virus 1human tissuemacrophagemicroglianervous system infectionneuronsneurotropic virusnucleic acid repetitive sequenceoligodendrogliatissue /cell culturevirulencevirus cytopathogenic effectvirus geneticsvirus infection mechanismvirus replicationwestern blottings
National Institute of Neurological Disorders and Stroke
CFDA Code
DUNS Number
042250712
UEI
GM1XX56LEP58
Project Start Date
01-March-1997
Project End Date
28-February-1998
Budget Start Date
01-October-1996
Budget End Date
30-September-1997
Project Funding Information for 1997
Total Funding
$181,575
Direct Costs
Indirect Costs
Year
Funding IC
FY Total Cost by IC
1997
National Institute of Neurological Disorders and Stroke
$181,575
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2P01NS027405-09 0001
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2P01NS027405-09 0001
Patents
No Patents information available for 2P01NS027405-09 0001
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2P01NS027405-09 0001
Clinical Studies
No Clinical Studies information available for 2P01NS027405-09 0001
News and More
Related News Releases
No news release information available for 2P01NS027405-09 0001
History
No Historical information available for 2P01NS027405-09 0001
Similar Projects
No Similar Projects information available for 2P01NS027405-09 0001